Biological effects of 2 different types of human insulin and monocomponent porcine insulin in normal subjects
Lamberti, C.; Tarzia, I.; Mancini, F.; Di Benedetto, A.; De Leo, A.; Giunta, E.; Giannetti, C.; Cucinotta, D.
Recenti Progressi in Medicina 76(11): 558-562
1985
ISSN/ISBN: 0034-1193 PMID: 3912872 Document Number: 260530
Document emailed within 1 workday
Related Documents
Mohan, V.; Shyamsundar, R.; Ramachandran, A.; Viswanathan, M.; Snehalatha, C. 1983: Allergy to monocomponent porcine and human insulin Journal of the Association of Physicians of India 31(11): 721-722Larkins, R.G.; Zajac, J.; Saunders, R.; Read, A.; Hopper, J.L. 1986: Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects Australian and New Zealand Journal of Medicine 16(2): 206-210
Wong, F.; Blendis, L.; Logan, A. 1997: Effects of insulin on renal function, sympathetic nervous activity and forearm blood flow in normal human subjects Clinical and Investigative Medicine. Medecine Clinique et Experimentale 20(5): 344-353
Piers, D.A.; Sluiter, W.J.; Reitsma, W.D.; Doorenbos, H. 1974: Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin Netherlands Journal of Medicine 17(4-5): 234-238
García de los Ríos, M.; Mella, I.; Durruty, P.; Ruiz, F.; López, G.; Tapia, J.C.; González, G. 1981: Effect of monocomponent insulin serum anti-insulin antibody levels Revista Medica de Chile 109(6): 509-515
Owens, D.R.; Vora, J.P.; Heding, L.G.; Luzio, S.; Ryder, R.E.; Atiea, J.; Hayes, T.M. 1986: Human, porcine and bovine ultralente insulin: subcutaneous administration in normal man Diabetic Medicine: a Journal of the British Diabetic Association 3(4): 326-329
Korányi, L.; Tamás, G.; Gerö, L.; Halmos, T.; Baranyai, E.; Büki, B. 1981: Glucagon antibodies in the blood of insulin-treated diabetics (effect of monospecific and monocomponent insulin therapy on antibody level) Orvosi Hetilap 122(23): 1371-1374
Kautzky, L.; Korányi, L.; Gerö, L.; Halmos, T.; Orosz, A. 1987: Binding of human and porcine insulin to erythrocyte and monocyte receptors in healthy subjects and type i and Ii diabetic patients Orvosi Hetilap 128(13): 671-673
Waldhäusl, W.K.; Gasić, S.; Bratusch-Marrain, P.; Korn, A.; Nowotny, P. 1982: Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects American Journal of Physiology 243(6): E476-E482
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
Davalli, A.M.; Ogawa, Y.; Scaglia, L.; Wu, Y.J.; Hollister, J.; Bonner-Weir, S.; Weir, G.C. 1994: Porcine islet grafts in diabetic nude mice: dynamic insulin secretion and regulated B-cell mass lower glucose levels to the normal porcine range Transplantation Proceedings 26(3): 1098-1099
Calafiore, R.; Pietropaolo, M.; Basta, G.; Calcinaro, F. 1985: Biguanides and glucidic homeostasis: effects of metformin and phenformin on the intermediate metabolism and insulin receptors of normal subjects Recenti Progressi in Medicina 76(3): 152-153
Inczefi-Gonda, A.; Csaba, G.; Dobozy, O.; Mohnike, K. 1988: Influence of neonatal treatment with porcine insulin (hormonal imprinting) on the receptor binding of insulins of porcine, rat and human origin Acta Physiologica Hungarica 72(3-4): 285-289
Escalante-Pulido, M.; Escalante-Herrera, A.; Milke-Najar, M.E.; Alpizar-Salazar, M. 2003: Effects of weight loss on insulin secretion and in vivo insulin sensitivity in obese diabetic and non-diabetic subjects Diabetes Nutrition and Metabolism 16(5-6): 277-283
Gatti, A.; Dell'Aversano, R.; Monda, M.; Bonavita, M.; Bocchino, C.; Giacometti, F.; Carleo, R. 1987: Evaluation of the effects of the transition from animal insulin to biosynthetic human insulin Bollettino della Societa Italiana di Biologia Sperimentale 63(7): 597-604; 610-611
Fagerberg, S.E.; Gamstedt, A. 1976: Experiences with monocomponent insulin Lakartidningen 73(47): 4097-4099
Rodriguez-Miñon, J.L.; Rios, M.S. 1978: Monocomponent insulin: general considerations Journees Annuelles de Diabetologie de l'Hotel-Dieu 1978: 109-122
Korp, W.; Levett, R.E. 1973: Experiences with monocomponent insulin treatment Wiener Klinische Wochenschrift 85(18): 326-330
Kato, M. 1998: Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes Hokkaido Journal of Medical Science 73(6): 613-625
Goto, T.; Onuma, T.; Takebe, K.; Kral, J.G. 1995: The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 19(12): 841-845